Search for stocks /

Artemis Medicare: 44.5% Promoter Pledge and Still Asking Patients to Trust Them?


1. At a Glance

Artemis Medicare Services Ltd (₹219 a pop, down nearly 24% in a year) wants you to believe that it’s North India’s five-star hotel disguised as a hospital. They run an 800+ bed chain (with Gurgaon as the flagship) and even brag about having “the first private geriatrics and longevity department.” Cute. But peel the bandage and you see a promoter pledge of 44.5%—that’s like your doctor pawning his stethoscope before surgery. Meanwhile, margins look healthy (EBITDA ~19%, PAT margin 8–9%), but the valuation P/E of ~35x screams “ICU patient” compared to peers trading higher.


2. Introduction

Welcome to Artemis Medicare—a hospital chain promoted by the same people who brought you Apollo Tyres. Imagine the mindset: if tyres burst on highways, hospitals next door can treat the injured. Vertical integration at its sarcastic best.

The company loves being “multi-specialty”—a fancy way of saying “anything that brings billing.” From oncology to neurosurgery, bariatrics to cosmetic add-ons, they’re not leaving any wallet unturned. They’ve also started Artemis Lite, Daffodils (luxury maternity), and a JV with Philips for cardiac care in Tier-2 towns—basically Apollo Tyres’ cousins trying to cosplay Apollo Hospitals.

But let’s not be too harsh—Artemis has grown revenue at a 10% CAGR and profits at 32% CAGR over 5 years. In FY25, they clocked ₹9,819 crore gross revenue and ₹822 crore PAT. Not bad for a Gurgaon setup that only started in 2007.

Still, the pledge elephant in the room doesn’t go away. The promoters clearly believe in “healthcare is wealth”—just not enough to keep their wealth unpledged.

Question to you, dear reader: would you admit yourself to a hospital where the promoter is financially admitted to a bank ICU?


3. Business Model – WTF Do They Even Do?

Artemis runs a chain of hospitals, but their bread and butter is the Gurgaon flagship. They are now scaling up with:

  • Artemis Hospital Gurgaon: 700+ beds, JCI accreditation, CyberKnife (no, not a Marvel weapon, just cancer tech).
  • Expansion Towers: They keep opening new towers like a hospital version of DLF Cyber City.
  • Artemis Lite: Smaller clinics—think of it as Apollo Clinics but with Gurgaon air quality included free.
  • Daffodils: Luxury mother-and-child hospitals, because why not monetize pregnancy?
  • Artemis Cardiac Care JV with Philips: Opening cardiac centres in Tier-2/3 cities, essentially outsourcing angioplasty to small-town India.
  • Overseas ventures: One hospital in Mauritius (Curepipe) and plans for more abroad.

It’s a mix of asset-heavy (main hospital) and asset-light (satellite clinics), with one thing in common: you pay, they admit.

Does the model sound sustainable or like another Indian SaaS—Scale As A Scam?


4. Financials Overview

MetricQ1 FY26Q1 FY25Q4 FY25YoY %QoQ %
Revenue (₹ Cr)2,4982,1692,34815.2%6.4%
EBITDA (₹ Cr)47840147819.4%0.1%
PAT (₹ Cr)21416923226.6%-7.7%
EPS (₹)1.541.211.6827%-8%

Annualised EPS = ₹1.54 × 4 = ₹6.16
CMP = ₹219 → P/E ~ 35.5x

Commentary: EPS is growing, but QoQ dip in PAT shows healthcare is seasonal—apparently Gurgaon flu doesn’t strike every quarter.


5. Valuation – Fair Value Range Only

  • P/E method: EPS ₹6.16 × Industry band (25–40x) → ₹154–₹246
  • EV/EBITDA: EBITDA FY25 = ₹1,828 Cr, EV = ₹2,930 Cr → EV/EBITDA ~16x. Peer band 15–22x → range = ₹210–₹308
  • DCF (assume 10% growth, 12% WACC) → ballpark ₹180–₹260

Fair Value Range: ₹180 – ₹260
(Educational only. Not investment advice. Doctors still charge consultation fees even if wrong, so do we.)


6. What’s Cooking – News, Triggers, Drama

  • MoU with VIMHANS, Delhi: A ₹550–600 Cr expansion, basically planting their flag in central Delhi.
  • IFC funding ₹330 Cr: When the World Bank’s arm funds you, they’re not doing charity—it means debt will come with ESG lectures.
  • New geriatrics department: Great, now Gurgaon’s retired uncles can get world-class treatment for gossip-related blood pressure.
  • Heart-lung transplant tie-up with KIMS: Sounds great, but aren’t most lungs in NCR
error: Content is protected !!